Multidisciplinary decisions in breast cancer: does the patient receive what the team has recommended?

by Rajan, S, Foreman, J, Wallis, M G, Caldas, C, Britton, P
Published 2013

Aurora kinase A outperforms Ki67 as a prognostic marker in ER-positive breast cancer

by Ali, H R, Dawson, S-J, Blows, F M, Provenzano, E, Pharoah, P D, Caldas, C
Published 2012

Reasons for treatment discontinuation in the first year after beginning antiretroviral therapy in a cohort of Portuguese HIV-infected patients

by Caldas, C, Andrade, P, Azevedo, C, Piñeiro, C, Serrão, R, Soares, J, Marques, R, Sarmento, A
Published 2010

Elevated expression of STK3 mRNA and protein is associated with poor outcome in invasive breast cancer

by Ojiegbe, S., Joseph, C., Provenzano, E., Caldas, C., Nolan, C., Green, A.R., Rakha, E., Ellis, I.O., Mukherjee, A.
Published 2017

Cell division cycle 25C (CDC25C) expression confers poor prognosis in invasive breast cancer

by Ojiegbe, S., Joseph, C., Provenzano, E., Caldas, C., Nolan, C., Green, A.R., Rakha, E., Ellis, I.O., Mukherjee, A.
Published 2017

NRG1 is frequently silenced by methylation in breast cancers and is a strong candidate for the 8p tumour suppressor gene

by Chua, Y-L, Ito, Y, Pole, JCM, Chin, S-F, Ellis, IO, Caldas, C, O'Hare, MJ, Murrell, AM, Edwards, PAW
Published 2008

Nuclear CSPP1 expression defined subtypes of basal-like breast cancer

by Sternemalm, J, Russnes, H G, Zhao, X, Risberg, B, Nord, S, Caldas, C, Børresen-Dale, A L, Stokke, T, Patzke, S
Published 2014

Associations between genomic stratification of breast cancer and centrally reviewed tumour pathology in the METABRIC cohort

by Mukherjee, A., Russell, R., Chin, Suet-Feung, Liu, B., Rueda, O.M., Ali, H.R., Turashvili, G., Mahler-Araujo, B., Ellis, I.O., Aparicio, S., Caldas, C., Provenzano, E.
Published 2018

Phenotypic and functional characterisation of the luminal cell hierarchy of the mammary gland

by Shehata, M., Teschendorff, A., Sharp, Gemma, Novcic, N., Russell, I., Avril, S., Prater, M., Eirew, P., Caldas, C., Watson, C., Stingl, J.
Published 2012

Loss of MED23 leads to poor prognosis in invasive breast cancer

by Aliyeva, T.A., Joseph, C., Provenzano, E., Russell, R., Caldas, C., Sonbul, S., Nolan, C., Green, A.R., Rakha, E.A, Ellis, IO., Mukherjee, A.
Published 2017

The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape

by Modelska, A., Turro, E., Russell, R., Beaton, J., Sbarrato, T., Spriggs, Keith, Miller, J., Graf, S., Provenzano, E., Blows, F., Pharoah, P., Caldas, C., Le Quesne, John
Published 2015

Chromosome translocations in breast cancer

by Howarth, K, Blood, K, Ng, B, Beavis, J, Chua, Y, Cooke, S, Pole, J, Chin, S, Ichimura, K, Collins, VP, Ellis, I, Caldas, C, Carter, N, Edwards, PAW
Published 2008

A central review of histopathology reports after breast cancer neoadjuvant chemotherapy in the neo-tango trial

by Provenzano, E, Vallier, A-L, Champ, R, Walland, K, Bowden, S, Grier, A, Fenwick, N, Abraham, J, Iddawela, M, Caldas, C, Hiller, L, Dunn, J, Earl, H M
Published 2013

Astronomical algorithms for automated analysis of tissue protein expression in breast cancer

by Ali, H R, Irwin, M, Morris, L, Dawson, S-J, Blows, F M, Provenzano, E, Mahler-Araujo, B, Pharoah, P D, Walton, N A, Brenton, J D, Caldas, C
Published 2013

The malignant phenotype in breast cancer is driven by eIF4A1-mediated changes in the translational landscape

by Modelska, A, Turro, E, Russell, R, Beaton, J, Sbarrato, T, Spriggs, K, Miller, J, Gräf, S, Provenzano, E, Blows, F, Pharoah, P, Caldas, C, Le Quesne, J
Published 2015

Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution

by Shah, S., Morin, R., Khattra, J., Prentice, L., Pugh, T., Burleigh, A., Delaney, A., Gelmon, K., Guliany, R., Senz, J., Steidl, C., Holt, R., Jones, S., Sun, M., Leung, G., Moore, R., Severson, T., Taylor, G., Teschendorff, A., Tse, K., Turashvili, G., Varhol, Richard, Warren, R., Watson, P., Zhao, Y., Caldas, C., Huntsman, D., Hirst, M., Marra, M., Aparicio, S.
Published 2009

Adjuvant epirubicin followed by cyclophosphamide, methotrexate and fluorouracil (CMF) vs CMF in early breast cancer: results with over 7 years median follow-up from the randomised...

by Earl, H M, Hiller, L, Dunn, J A, Vallier, A-L, Bowden, S J, Jordan, S D, Blows, F, Munro, A, Bathers, S, Grieve, R, Spooner, D A, Agrawal, R, Fernando, I, Brunt, A M, O'Reilly, S M, Crawford, S M, Rea, D W, Simmonds, P, Mansi, J L, Stanley, A, McAdam, K, Foster, L, Leonard, R CF, Twelves, C J, Cameron, D, Bartlett, J MS, Pharoah, P, Provenzano, E, Caldas, C, Poole, C J
Published 2012

The clonal and mutational evolution spectrum of primary triple-negative breast cancers

by Shah, S., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., Bashashati, A., Prentice, L., Khattra, J., Burleigh, A., Yap, D., Bernard, V., McPherson, A., Shumansky, K., Crisan, A., Giuliany, R., Heravi-Moussavi, A., Rosner, J., Lai, D., Birol, I., Varhol, Richard, Tam, A., Dhalla, N., Zeng, T., Ma, K., Chan, S., Griffith, M., Moradian, A., Cheng, S., Morin, G., Watson, P., Gelmon, K., Chia, S., Chin, S., Curtis, C., Rueda, O., Pharoah, P., Damaraju, S., MacKey, J., Hoon, K., Harkins, T., Tadigotla, V., Sigaroudinia, M., Gascard, P., Tlsty, T., Costello, J., Meyer, I., Eaves, C., Wasserman, W., Jones, S., Huntsman, D., Hirst, M., Caldas, C., Marra, M., Aparicio, S.
Published 2012

PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2

by Wishart, G C, Bajdik, C D, Dicks, E, Provenzano, E, Schmidt, M K, Sherman, M, Greenberg, D C, Green, A R, Gelmon, K A, Kosma, V-M, Olson, J E, Beckmann, M W, Winqvist, R, Cross, S S, Severi, G, Huntsman, D, Pylkäs, K, Ellis, I, Nielsen, T O, Giles, G, Blomqvist, C, Fasching, P A, Couch, F J, Rakha, E, Foulkes, W D, Blows, F M, Bégin, L R, van't Veer, L J, Southey, M, Nevanlinna, H, Mannermaa, A, Cox, A, Cheang, M, Baglietto, L, Caldas, C, Garcia-Closas, M, Pharoah, P D P
Published 2012